We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics

Eurofins Technologies

  Gold Eurofins Technologies, part of the Eurofins Scientific group, is a fast-growing, global provider of diagnostic test k... read more Featured Products: More products

Download Mobile App

Eurofins Viracor Launches Coronavirus SARS-CoV-2 inSIGHT T Cell Immunity Testing to Aid COVID-19 Treatment Decisions

By LabMedica International staff writers
Posted on 23 Jul 2021
Print article
Eurofins Viracor (Lee's Summit, MO, USA) has become one of the first commercial labs to deliver COVID-19 testing with the launch of Coronavirus SARS-CoV-2 inSIGHT T Cell Immunity testing.

Viracor’s inSIGHT T Cell Immunity test delivers an understanding of a patient's response to viral antigens providing critical insight to aid in treatment decisions. The test measures CD4+ and CD8+ T Cell response to the SARS-CoV-2 spike (S) and nucleocapsid (N) proteins to independently evaluate cell-mediated immunity to Coronavirus SARS-CoV-2 that causes COVID-19. The test measures CD4+ and CD8+ T Cell response to the SARS-CoV-2 spike (S) and nucleocapsid (N) proteins to independently evaluate cell-mediated immunity to Coronavirus SARS-CoV-2 that causes COVID-19. Utilizing flow cytometry and intracellular cytokine staining, SARS-CoV-2 inSIGHT testing could be an important tool for evaluating immunological memory to the SARS-CoV-2 virus, and even indicate a level of protection from further infection.

SARS-CoV-2 inSIGHT testing joins a robust menu of COVID-19 testing, including the recently-launched cPASS Coronavirus SARS-CoV-2 Neutralizing Antibody test. When used in combination with the Neutralizing Antibody test, results from the tests could help physicians evaluate two areas of our adaptive immune system that can indicate immunity. When neutralizing antibody response begins to diminish months after exposure to the virus or vaccine, the presence of T cell immunity may signify long-term immunity.

Related Links:
Eurofins Viracor

Gold Supplier
SARS-CoV-2 Multiplex Real-Time RT-PCR Assay
GSD NovaPrime Plus SARS-CoV-2
Neonatal Analyzer
CareStart S1 Analyzer
IFA Automated Processor
Gold Supplier
Rapid PCR Diagnostic System
Accula System

Print article


Clinical Chem.

view channel
VIASURE HLA Celiac Real Time PCR Detection Kit

CerTest VIASURE HLA Celiac RT PCR Kit Enables Rapid Resolution of HLA Haplotypes Associated with Celiac Disease

CerTest Biotec (Zaragoza, Spain) has developed a simple and ready to use real-time PCR for the detection of the principal alleles of the HLA system and the subsequent determination of the DQ2 and DQ8 antigens... Read more


view channel

First-Of-Its Kind Blood Test to Distinguish between Bacterial and Viral Infections Using Body’s Immune Response Granted FDA Clearance

A first-of-its kind test that decodes the immune response to accurately distinguish between bacterial or viral infections within minutes has been granted clearance by the US Food and Drug Administration (FDA).... Read more


view channel
Image: The CellSearch Circulating Tumor Cell Kit is intended for the enumeration of circulating tumor cells of epithelial origin (CD45-, EpCAM+, and cytokeratins 8, 18+, and/or 19+ and PD-L1) in whole blood (Photo courtesy of CellSearch/Menarini Silicon Biosystems)

PD-L1 Expression in Circulating Tumor Cells Investigated for NSCLC

In non-small cell lung cancer (NSCLC), analysis of programmed cell death ligand 1 (PD-L1) expression in circulating tumor cells (CTCs) is a potential alternative to overcome the problems linked to the... Read more


view channel

Thermo Fisher Launches World’s First Fully Integrated Digital PCR (dPCR) System

Thermo Fisher Scientific Inc. (Waltham, MA, USA) has launched the world’s first fully integrated digital PCR (dPCR) system designed to provide highly accurate and consistent results within 90 minutes.... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.